Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jeffrey Kirshner MD, FACP, FASCO
Jeffrey J. Kirshner MD, FACP, FASCO Advisory Board
Jean-Yves Douillard MD, PhD
Jean-Yves Douillard MD, PhD Advisory Board
Annette Hasenburg Prof., Dr, med
Annette Hasenburg Prof., Dr, med Advisory Board
See All Experts
featured
Published in Oncology and
1 other channel

Journal Scan / Research · March 13, 2019

Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab

JACC: Heart Failure

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Joerg Herrmann MD

JACC: Heart Failure
Long-Term Risk of Heart Failure in Breast Cancer Patients After Adjuvant Chemotherapy With or Without Trastuzumab
JACC Heart Fail 2019 Mar 01;7(3)217-224, A Banke, EL Fosbøl, M Ewertz, L Videbæk, JS Dahl, MK Poulsen, S Cold, MB Jensen, GH Gislason, M Schou, JE Møller

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Recently Updated